GlaxoSmithKline (GSK)

NYSE:GSK

US Market

GSK

GlaxoSmithKline

RESEARCH TOOLSreports

Want to see GSK full AI Analyst Report?

GlaxoSmithKline (GSK) Ownership - Who Owns GlaxoSmithKline?

5,232 Followers

GlaxoSmithKline (GSK) Ownership Overview

6.65% Mutual Funds

8.91% Other Institutional Investors

0.35% ETFs

84.09% Public Companies and Individual Investors

The ownership structure of GlaxoSmithKline (GSK) stock is a mix of institutional, retail, and individual investors. Approximately 15.91% of the company’s stock is owned by Institutional Investors, and 84.09% is owned by Public Companies and Individual Investors.

The ownership structure of GlaxoSmithKline (GSK) stock is a mix of institutional, retail, and individual investors. Approximately 9.26% of the company’s stock is owned by Institutional Investors, 6.65% is owned by Insiders, and 84.09% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Tweedy Browne Co Llc	xxxxxxxxxxxxx	$4513714
Mar 31, 2024	Pzena Investment Management Llc	xxxxxxxxxxxxx	$1038841
Mar 31, 2024	Causeway Capital Management Llc	xxxxxxxxxxxxx	$613161
Mar 31, 2024	Dodge & Cox	xxxxxxxxxxxxx	$3237609535

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
John A. Gunn	58,662,974	Institution	2.89%	3,022,903,050
	55,475,472	Institution	2.74%	2,858,651,072
Ken Fisher	34,522,363	Institution	1.70%	1,778,937,365
Theofanis Kolokotrones	25,204,538	Institution	1.24%	1,298,789,843
	18,142,650	Institution	0.90%	934,890,755
	9,185,065	Institution	0.45%	473,306,399
	7,943,164	Institution	0.39%	409,311,241
	5,702,194	Institution	0.28%	293,834,057
	4,447,100	Institution	0.22%	229,159,063
	3,544,080	Institution	0.17%	182,626,442

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	55,475,472	Institution	2.74%	2,858,651,072
	18,142,650	Institution	0.90%	934,890,755
	9,185,065	Institution	0.45%	473,306,399
	7,943,164	Institution	0.39%	409,311,241
	5,702,194	Institution	0.28%	293,834,057
	4,447,100	Institution	0.22%	229,159,063
	3,544,080	Institution	0.17%	182,626,442
	3,487,775	Institution	0.17%	179,725,046
	3,053,917	Institution	0.15%	157,368,343
	2,734,200	Institution	0.13%	140,893,326

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Avantis International Equity ETF	1,261,311	Institution	0.06%	62,825,901
Fidelity Enhanced International ETF	991,305	Institution	0.05%	49,376,902
VanEck Pharmaceutical ETF	789,487	Institution	0.04%	39,324,347
First Trust Value Line Dividend Index Fund	599,620	Institution	0.03%	30,898,419
Fidelity Tactical High Income Fund Trust Units	591,200	Institution	0.03%	47,683,991
Avantis International Large Cap Value ETF	280,196	Institution	0.01%	13,956,563
Hartford Multifactor Developed Markets (ex-US) ETF	252,568	Institution	0.01%	12,580,412
GMO International Value ETF	249,672	Institution	0.01%	12,436,162
AQE Core ETF	213,396	Institution	0.01%	10,629,255
Evolve Global Healthcare Enhanced Yield Fund Trust Units USD Unhedged	196,564	Institution	<0.01%	13,392,418

FAQ

Who Owns GlaxoSmithKline (GSK)?

Currently, no data Available

What percentage of GlaxoSmithKline (GSK) stock is held by institutional investors?

According to the latest TipRanks data, approximately 8.91% of GlaxoSmithKline (GSK) stock is held by institutional investors.

What percentage of GlaxoSmithKline (GSK) stock is held by retail investors?

According to the latest TipRanks data, approximately 84.09% of GlaxoSmithKline (GSK) stock is held by retail investors.

Who owns the most shares of GlaxoSmithKline (GSK)?

John A. Gunn owns the most shares of GlaxoSmithKline (GSK).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.